Follow
Esther Aguilar
Title
Cited by
Cited by
Year
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
EJ Aguilar, B Ricciuti, JF Gainor, KL Kehl, S Kravets, S Dahlberg, ...
Annals of Oncology 30 (10), 1653-1659, 2019
2622019
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression≥ 50%
JF Gainor, H Rizvi, EJ Aguilar, F Skoulidis, BY Yeap, J Naidoo, ...
Annals of Oncology 31 (3), 404-411, 2020
932020
Metabolic reprogramming and dependencies associated with epithelial cancer stem cells independent of the epithelial-mesenchymal transition program
E Aguilar, I Marin de Mas, E Zodda, S Marin, F Morrish, V Selivanov, ...
Stem cells 34 (5), 1163-1176, 2016
902016
A key role for transketolase-like 1 in tumor metabolic reprogramming
S Diaz-Moralli, E Aguilar, S Marin, JF Coy, M Dewerchin, MR Antoniewicz, ...
Oncotarget 7 (32), 51875, 2016
562016
LKB1 deficiency in T cells promotes the development of gastrointestinal polyposis
MC Poffenberger, A Metcalfe-Roach, E Aguilar, J Chen, BE Hsu, ...
Science 361 (6400), 406-411, 2018
532018
Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells
I Marin de Mas, E Aguilar, E Zodda, C Balcells, S Marin, G Dallmann, ...
PLOS Computational Biology 14 (1), e1005914, 2018
432018
Cancer cell metabolism as new targets for novel designed therapies
IM de Mas, E Aguilar, A Jayaraman, IH Polat, A Martín-Bernabé, R Bharat, ...
Future medicinal chemistry 6 (16), 1791-1810, 2014
322014
Mitochondrial protein UCP2 controls pancreas development
B Broche, S Ben Fradj, E Aguilar, T Sancerni, M Bénard, F Makaci, ...
Diabetes 67 (1), 78-84, 2018
312018
Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle
M Zanuy, A Ramos-Montoya, O Villacanas, N Canela, A Miranda, ...
Metabolomics 8, 454-464, 2012
302012
STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov. 2018; 8 (7): 822–835. doi: 10.1158/2159-8290
F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ...
CD-18-0099, 0
27
STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov 8: 822–835
F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ...
162018
MIDcor, an R-program for deciphering mass interferences in mass spectra of metabolites enriched in stable isotopes
VA Selivanov, A Benito, A Miranda, E Aguilar, IH Polat, JJ Centelles, ...
BMC bioinformatics 18, 1-9, 2017
152017
The system can't perform the operation now. Try again later.
Articles 1–12